Autonomix Medical, Inc. (NASDAQ:AMIX) Sees Large Drop in Short Interest

Autonomix Medical, Inc. (NASDAQ:AMIXGet Free Report) saw a large drop in short interest in the month of December. As of December 15th, there was short interest totaling 133,864 shares, a drop of 62.1% from the November 30th total of 353,480 shares. Currently, 2.1% of the company’s shares are short sold. Based on an average daily volume of 221,552 shares, the days-to-cover ratio is presently 0.6 days. Based on an average daily volume of 221,552 shares, the days-to-cover ratio is presently 0.6 days. Currently, 2.1% of the company’s shares are short sold.

Autonomix Medical Stock Performance

Shares of NASDAQ AMIX opened at $0.58 on Friday. Autonomix Medical has a 1 year low of $0.56 and a 1 year high of $4.58. The stock’s 50-day simple moving average is $0.88 and its 200-day simple moving average is $1.12. The firm has a market cap of $3.98 million, a price-to-earnings ratio of -0.12 and a beta of -2.87.

Autonomix Medical (NASDAQ:AMIXGet Free Report) last issued its quarterly earnings results on Wednesday, November 12th. The company reported ($1.38) EPS for the quarter, meeting analysts’ consensus estimates of ($1.38). As a group, research analysts predict that Autonomix Medical will post -10 EPS for the current year.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Autonomix Medical in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Autonomix Medical has an average rating of “Hold” and a consensus target price of $5.00.

Read Our Latest Research Report on AMIX

About Autonomix Medical

(Get Free Report)

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

Featured Stories

Receive News & Ratings for Autonomix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Autonomix Medical and related companies with MarketBeat.com's FREE daily email newsletter.